BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 37240077)

  • 41. Promoter hypermethylation in ductal carcinoma in situ of the male breast.
    Vermeulen MA; van Deurzen CHM; Doebar SC; de Leng WWJ; Martens JWM; van Diest PJ; Moelans CB
    Endocr Relat Cancer; 2019 Jun; 26(6):575-584. PubMed ID: 30921768
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analysis of loss of heterozygosity on chromosome 11q13 in atypical ductal hyperplasia and in situ carcinoma of the breast.
    Chuaqui RF; Zhuang Z; Emmert-Buck MR; Liotta LA; Merino MJ
    Am J Pathol; 1997 Jan; 150(1):297-303. PubMed ID: 9006344
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of copy number alterations associated with the progression of DCIS to invasive ductal carcinoma.
    Johnson CE; Gorringe KL; Thompson ER; Opeskin K; Boyle SE; Wang Y; Hill P; Mann GB; Campbell IG
    Breast Cancer Res Treat; 2012 Jun; 133(3):889-98. PubMed ID: 22052326
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ectopic expression of PLC-β2 in non-invasive breast tumor cells plays a protective role against malignant progression and is correlated with the deregulation of miR-146a.
    Bertagnolo V; Grassilli S; Volinia S; Al-Qassab Y; Brugnoli F; Vezzali F; Lambertini E; Palomba M; Piubello Q; Orvieto E; Natali C; Piva R; Croce CM; Capitani S
    Mol Carcinog; 2019 May; 58(5):708-721. PubMed ID: 30582225
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A systematic review of long non-coding RNAs with a potential role in breast cancer.
    Heidari R; Akbariqomi M; Asgari Y; Ebrahimi D; Alinejad-Rokny H
    Mutat Res Rev Mutat Res; 2021; 787():108375. PubMed ID: 34083033
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long Non-Coding RNAs, Cell Cycle, and Human Breast Cancer.
    Yin Q; Ma H; Bamunuarachchi G; Zheng X; Ma Y
    Hum Gene Ther; 2023 Jun; 34(11-12):481-494. PubMed ID: 37243445
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An extracellular matrix stiffness-induced breast cancer cell transcriptome resembles the transition from ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC).
    Göransson S; Chen S; Olofsson H; Larsson O; Strömblad S
    Biochem Biophys Res Commun; 2023 Apr; 654():73-79. PubMed ID: 36893606
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Profiling differential microRNA expression between in situ, infiltrative and lympho-vascular space invasive breast cancer: a pilot study.
    Soon PS; Provan PJ; Kim E; Pathmanathan N; Graham D; Clarke CL; Balleine RL
    Clin Exp Metastasis; 2018 Feb; 35(1-2):3-13. PubMed ID: 29214365
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intraductal carcinoma (ductal carcinoma in situ) of the breast. A comparison of pure noninvasive tumors with those including different proportions of infiltrating carcinoma.
    Moriya T; Silverberg SG
    Cancer; 1994 Dec; 74(11):2972-8. PubMed ID: 7954261
    [TBL] [Abstract][Full Text] [Related]  

  • 50. PIK3CA mutations in ductal carcinoma in situ and adjacent invasive breast cancer.
    Agahozo MC; Sieuwerts AM; Doebar SC; Verhoef EI; Beaufort CM; Ruigrok-Ritstier K; de Weerd V; Sleddens HFBM; Dinjens WNM; Martens JWM; van Deurzen CHM
    Endocr Relat Cancer; 2019 May; 26(5):471-482. PubMed ID: 30844755
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Classification of ductal carcinoma in situ by gene expression profiling.
    Hannemann J; Velds A; Halfwerk JB; Kreike B; Peterse JL; van de Vijver MJ
    Breast Cancer Res; 2006; 8(5):R61. PubMed ID: 17069663
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 21-Gene Assay and Breast Cancer Mortality in Ductal Carcinoma In Situ.
    Rakovitch E; Sutradhar R; Nofech-Mozes S; Gu S; Fong C; Hanna W; Paszat L
    J Natl Cancer Inst; 2021 May; 113(5):572-579. PubMed ID: 33369631
    [TBL] [Abstract][Full Text] [Related]  

  • 53. New insights into long non-coding RNAs in breast cancer: Biological functions and therapeutic prospects.
    Wang MQ; Zhu WJ; Gao P
    Exp Mol Pathol; 2021 Jun; 120():104640. PubMed ID: 33878314
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ID2 and GJB2 promote early-stage breast cancer progression by regulating cancer stemness.
    Liu Y; Pandey PR; Sharma S; Xing F; Wu K; Chittiboyina A; Wu SY; Tyagi A; Watabe K
    Breast Cancer Res Treat; 2019 May; 175(1):77-90. PubMed ID: 30725231
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative effectiveness of incorporating a hypothetical DCIS prognostic marker into breast cancer screening.
    Trentham-Dietz A; Ergun MA; Alagoz O; Stout NK; Gangnon RE; Hampton JM; Dittus K; James TA; Vacek PM; Herschorn SD; Burnside ES; Tosteson ANA; Weaver DL; Sprague BL
    Breast Cancer Res Treat; 2018 Feb; 168(1):229-239. PubMed ID: 29185118
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Spotlight on Exosomal Non-Coding RNAs in Breast Cancer: An In Silico Analysis to Identify Potential lncRNA/circRNA-miRNA-Target Axis.
    Ashekyan O; Abdallah S; Shoukari AA; Chamandi G; Choubassy H; Itani ARS; Alwan N; Nasr R
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955480
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Single-cell genetic analysis of ductal carcinoma in situ and invasive breast cancer reveals enormous tumor heterogeneity yet conserved genomic imbalances and gain of MYC during progression.
    Heselmeyer-Haddad K; Berroa Garcia LY; Bradley A; Ortiz-Melendez C; Lee WJ; Christensen R; Prindiville SA; Calzone KA; Soballe PW; Hu Y; Chowdhury SA; Schwartz R; Schäffer AA; Ried T
    Am J Pathol; 2012 Nov; 181(5):1807-22. PubMed ID: 23062488
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long noncoding RNAs: new insights into non-small cell lung cancer biology, diagnosis and therapy.
    Ricciuti B; Mencaroni C; Paglialunga L; Paciullo F; Crinò L; Chiari R; Metro G
    Med Oncol; 2016 Feb; 33(2):18. PubMed ID: 26786153
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long non-coding RNAs differential expression in breast cancer subtypes: What do we know?
    Mathias C; Zambalde EP; Rask P; Gradia DF; de Oliveira JC
    Clin Genet; 2019 May; 95(5):558-568. PubMed ID: 30614523
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Il-6 signaling between ductal carcinoma in situ cells and carcinoma-associated fibroblasts mediates tumor cell growth and migration.
    Osuala KO; Sameni M; Shah S; Aggarwal N; Simonait ML; Franco OE; Hong Y; Hayward SW; Behbod F; Mattingly RR; Sloane BF
    BMC Cancer; 2015 Aug; 15():584. PubMed ID: 26268945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.